---
schema_version: "secwatch.filing_event.v1"
accession: "0000721371-24-000119"
form_type: "8-K"
ticker: "CAH"
cik: "0000721371"
company_name: "CARDINAL HEALTH INC"
filed_at: "2024-11-01T23:59:59+00:00"
generated_at: "2026-05-30T07:08:55.790509+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Cardinal Health Q1 GAAP EPS $1.70; Non-GAAP EPS $1.88, up 9% YoY; Raises FY25 guidance

## Summary
- Revenue $52.3B, down 4% (up 15% ex-large customer expiration); Pharmaceutical segment profit up 16% to $530M.
- Non-GAAP operating earnings $625M (+12%) driven by brand/specialty growth and early COVID vaccine distribution.
- Non-GAAP diluted EPS guidance raised to $7.75-$7.90 from $7.55-$7.70; adjusted free cash flow outlook now $1.0B-$1.5B.
- Announced $1.1B cash acquisition of Integrated Oncology Network, adding 100+ providers across 10 states.
- Completed $375M accelerated share repurchase in October; Global Medical Products segment profit fell to $8M from $12M.

## SEC filing metadata
- accession: 0000721371-24-000119
- form_type: 8-K
- ticker: CAH
- cik: 0000721371
- company_name: CARDINAL HEALTH INC
- filed_at: 2024-11-01T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/721371/000072137124000119/0000721371-24-000119-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/721371/000072137124000119/cah-20241101.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000721371-24-000119
- JSON: https://secwatch.observer/filing/0000721371-24-000119.json
- Plain text: https://secwatch.observer/filing/0000721371-24-000119.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.